FIELD: virology.
SUBSTANCE: invention relates to the field of virology. Disclosed is a method for monitoring COVID-19 morbidity. According to the method, it’s necessary to determine a correction factor (m) representing a lower limit for determining the morbidity rate and monitoring COVID-19 morbidity. To determine m, aliquots of fecal samples of patients with a confirmed diagnosis of COVID-19 are taken and diluted with model wastewater to obtain samples № 1 .... No p. Samples № 1 .... No p undergo a serial dilution until the lower limit of determination of the real-time RT-PCR method is reached. After that the arithmetic mean value of the maximum degrees of dilution is averaged and calculated. The correction factor m is defined as the ratio of 100 to the arithmetic mean. RNA is isolated from wastewater samples with the purpose of monitoring. The samples are analyzed for the presence of SARS-CoV-2 viral particles. If the result is negative, the morbidity rate is 0%. If the result is positive, serial dilutions of wastewater samples are prepared until the lower limit of determination of the real-time RT-PCR method is reached. After that the maximum degree of dilution of wastewater (k) is determined. The value of the morbidity rate of COVID-19 (N,%) is calculated in accordance with the formula N = k * m.
EFFECT: improved accuracy of results and reduced duration of sample analysis.
1 cl, 2 ex, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
REAGENT KIT FOR DETECTION OF SARS-COV-2 VIRUS RNA BY REAL-TIMR POLYMERASE CHAIN REACTION | 2022 |
|
RU2795939C2 |
SET OF SYNTHETIC OLIGODEOXYRIBONUCLEOTIDES AND A METHOD FOR QUANTIFYING THE VIRAL LOAD OF SARS-CoV-2 IN TISSUES OF VARIOUS ORGANS BY QUANTITATIVE POLYMERASE CHAIN REACTION IN REAL TIME | 2021 |
|
RU2761358C1 |
TEST SYSTEM AND METHOD FOR DETECTING RNA OF CORONAVIRUS SARS-COV-2, VIRUS-AGENT OF CORONAVIRUS DISEASE 2019 COVID-19, BY POLYMERASE CHAIN REACTION IN REAL TIME (EMBODIMENTS) | 2020 |
|
RU2731390C1 |
REAGENT SET FOR DETECTING RNA OF SARS-COV-2 VIRUS, CAUSATIVE AGENT OF NEW CORONAVIRUS DISEASE COVID-2019, BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION IN REAL TIME | 2020 |
|
RU2732608C1 |
AN ANTIVIRAL AGENT AGAINST SARS-COV-2 CORONAVIRUS | 2022 |
|
RU2788762C1 |
STRAIN OF HCOV-19/RUSSIA/OMSK-202118-1707/2020 OF SARS-COV-2 CORONAVIRUS, IMMUNOSORBENT CONTAINING PURIFIED WHOLE VIRION ANTIGEN OBTAINED ON BASIS OF SPECIFIED STRAIN AND ISA TEST SYSTEM FOR DETECTING ANTIBODIES OF CLASSES M, G AND A TO SARS CORONAVIRUS-COV-2 USING SPECIFIED IMMUNOSORBENT | 2021 |
|
RU2752862C1 |
TEST SYSTEM FOR DETECTION OF SARS-COV-2 VIRUS RNA IN BIOMATERIAL FROM ANIMALS, FOOD AND ENVIRONMENTAL OBJECTS BY THE POLYMERASE CHAIN REACTION METHOD IN REAL TIME | 2021 |
|
RU2756474C1 |
METHOD FOR DETERMINING THE ACTIVITY OF NEUTRALISING ANTIBODIES AGAINST SARS-CoV-2 IN THE SERUM OR PLASMA OF PEOPLE WITH PAST CASES OF COVID-19 OR VACCINATED WITH PREVENTIVE VACCINES AGAINST THE NOVEL CORONAVIRUS INFECTION COVID-19 USING A SET OF ENZYME IMMUNOASSAY REAGENTS CONTAINING A RECOMBINANT RECEPTOR-BINDING DOMAIN (RBD) OF SURFACE GLYCOPROTEIN S OF CORONAVIRUS SARS-CoV-2 AND RECOMBINANT HUMAN RECEPTOR ACE2 | 2021 |
|
RU2784655C1 |
SET OF OLIGODEOXYRIBONUCLETIDE PRIMERS AND FLUORESCENT-LABELED PROBE FOR IDENTIFICATION OF RNA OF HUMAN CORONAVIRUSES SARS AND 2019-NCOV BY RT-PCR METHOD WITH HYBRIDIZATION-FLUORESCENT DETECTION IN REAL TIME | 2020 |
|
RU2733665C1 |
METHOD OF USING RECOMBINANT PROTEINS SARS-COV-2 AS PART OF A TEST SYSTEM FOR ELISA TEST WITH DETERMINING IGM, IGG, IGA CLASS ANTIBODY LEVELS IN BLOOD SERUM/PLASMA OF COVID-19 PATIENTS | 2020 |
|
RU2730897C1 |
Authors
Dates
2021-02-24—Published
2020-12-11—Filed